Top Vaccines companies in Sweden by Goodwill
Sweden
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 951.67 M
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
| 2 |
USD 558.03 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
| 3 |
USD 33.62 M
|
Dec. 31, 2023 | USD 31.05 | 0.32% |
|
Sweden |
|
| 4 |
USD 10.69 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
| 5 |
USD 6.24 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
| 6 |
USD 451.36 K
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
| 7 |
USD 0.10
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
| 8 |
USD 0.00
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
| 9 |
USD 0.00
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
| 10 |
USD 0.00
|
Aug. 31, 2023 | USD 1.49 | -4.08% |
|
Sweden |
|
| 11 |
USD 0.00
|
Dec. 31, 2023 | USD 1.26 | -1.32% |
|
Sweden |
|
| 12 |
USD 0.00
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
Frequently Asked Questions
-
Which Vaccines company in Sweden has the highest Goodwill ?
The Vaccines company in Sweden with the highest Goodwill is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 951.67 M.
-
Which Vaccines company in Sweden has the lowest Goodwill ?
The Vaccines company in Sweden with the lowest Goodwill is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at USD 0.00.
-
What are the top 10 Vaccines companies in Sweden by Goodwill ?
The top 10 Vaccines companies in Sweden by Goodwill are Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), Probi AB (publ), Mendus AB (publ), Enzymatica AB (publ), Genovis AB (publ.), Iconovo AB (publ), BioInvent International AB (publ), Moberg Pharma AB (publ) and Diamyd Medical AB (publ).
-
What are the bottom 10 Vaccines companies in Sweden by Goodwill ?
The bottom 10 Vaccines companies in Sweden by Goodwill are BioArctic AB (publ), SynAct Pharma AB, Diamyd Medical AB (publ), Moberg Pharma AB (publ), BioInvent International AB (publ), Iconovo AB (publ), Genovis AB (publ.), Enzymatica AB (publ), Mendus AB (publ) and Probi AB (publ).
